143 related articles for article (PubMed ID: 24486353)
1. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice.
Singh AK; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353
[TBL] [Abstract][Full Text] [Related]
2. Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis.
Gupta A; Narayan B; Kumar S; Verma SK
Front Immunol; 2020; 11():988. PubMed ID: 32595634
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Bivalent Fusion Protein rVE Induces CD4+ and CD8+ T-Cell Mediated Memory Immune Response for Protection Against Yersinia enterocolitica Infection.
Singh AK; Kingston JJ; Gupta SK; Batra HV
Front Microbiol; 2015; 6():1407. PubMed ID: 26733956
[TBL] [Abstract][Full Text] [Related]
4. A Combined YopB and LcrV Subunit Vaccine Elicits Protective Immunity against
Heine SJ; Franco-Mahecha OL; Sears KT; Drachenberg CB; van Roosmalen ML; Leenhouts K; Picking WL; Pasetti MF
J Immunol; 2019 Apr; 202(7):2005-2016. PubMed ID: 30787109
[No Abstract] [Full Text] [Related]
5. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
Vogel U; Autenrieth IB; Berner R; Heesemann J
Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
7. Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica.
Branger CG; Torres-Escobar A; Sun W; Perry R; Fetherston J; Roland KL; Curtiss R
Vaccine; 2009 Aug; 27(39):5363-70. PubMed ID: 19596407
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.
Miller NC; Quenee LE; Elli D; Ciletti NA; Schneewind O
Infect Immun; 2012 Apr; 80(4):1572-82. PubMed ID: 22252870
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity.
Schmidt A; Schaffelhofer S; Müller K; Röllinghoff M; Beuscher HU
Microb Pathog; 1999 Apr; 26(4):221-33. PubMed ID: 10089162
[TBL] [Abstract][Full Text] [Related]
11. Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice.
Cai K; Zhang Y; Yang B; Chen S
Vaccine; 2013 Jan; 31(2):334-40. PubMed ID: 23153438
[TBL] [Abstract][Full Text] [Related]
12. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
13. Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages.
Roggenkamp A; Leitritz L; Sing A; Kempf VA; Baus K; Heesemann J
Med Microbiol Immunol; 1999 Dec; 188(3):151-9. PubMed ID: 10776846
[TBL] [Abstract][Full Text] [Related]
14. [Oral infection by Y. enterocolitica 0:8. Studies of immunization in a murine model].
Frades MC; Díaz R
Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):608-12. PubMed ID: 1822150
[TBL] [Abstract][Full Text] [Related]
15. Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model.
Sing A; Tvardovskaia N; Rost D; Kirschning CJ; Wagner H; Heesemann J
Int J Med Microbiol; 2003 Nov; 293(5):341-8. PubMed ID: 14695062
[TBL] [Abstract][Full Text] [Related]
16. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.
Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B
Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495
[TBL] [Abstract][Full Text] [Related]
17. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
[TBL] [Abstract][Full Text] [Related]
18. Yersinia enterocolitica promotes robust mucosal inflammatory T-cell immunity in murine neonates.
Echeverry A; Saijo S; Schesser K; Adkins B
Infect Immun; 2010 Aug; 78(8):3595-608. PubMed ID: 20515925
[TBL] [Abstract][Full Text] [Related]
19. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.
Qi Z; Zhou L; Zhang Q; Ren L; Dai R; Wu B; Wang T; Zhu Z; Yang Y; Cui B; Wang Z; Wang H; Qiu Y; Guo Z; Yang R; Wang X
Vaccine; 2010 Feb; 28(6):1655-60. PubMed ID: 20079562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
